Literature DB >> 16126943

Crohn's disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population.

Zsuzsanna Nagy1, Oszkár Karádi, György Rumi, György Rumi, Alajos Pár, Gyula Mózsik, László Czirják, Gábor Süto.   

Abstract

Crohn's disease (CD) is commonly classified as an immune-mediated disorder, but genetic and environmental factors seem to be important in its pathogenesis. Mutations within the CARD15/NOD2 gene have been associated with CD in the Caucasian population. The aim of our work was to investigate the allele frequency and clinical impact of the three common mutations in Hungarian CD patients and healthy controls. Seventy-four CD patients and 107 controls were examined. The genotyping of the three common CARD15/NOD2 mutations (Arg702Trp, Gly908Arg, and Leu1007fsinsC) was carried out by restriction fragment length polymorphism (RFLP) and amplification refractory mutation system (ARMS) techniques. The demographic and clinical parameters were correlated with chi(2) analysis. The overall prevalence of CARD15/NOD2 mutations in the Hungarian CD patients (33.78%) was significantly higher than in healthy control individuals (16.23%) (P < 0.025). The allele frequency of the Gly908Arg mutation did not differ, but the Arg702Trp and Leu1007fsinsC mutation were more common in CD patients than in controls. The onset of CD occurs about three years earlier in CARD15/NOD2 carriers. Carriage of the Arg702Trp and Leu1007fsinsC allele within the CARD15/NOD2 gene is associated with CD. These data are in line with similar findings showing a role of the CARD15/NOD2 protein in the etiopathogenesis of CD. The genotyping of these mutations might be used to identify high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126943     DOI: 10.1196/annals.1361.045

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

Review 1.  Role of the intestinal barrier in inflammatory bowel disease.

Authors:  Mike G Laukoetter; Porfirio Nava; Asma Nusrat
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 2.  NOD2: ethnic and geographic differences.

Authors:  Juleen Cavanaugh
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.

Authors:  Veronika Csöngei; Luca Járomi; Eniko Sáfrány; Csilla Sipeky; Lili Magyari; Bernadett Faragó; Judit Bene; Noémi Polgár; Lilla Lakner; Patrícia Sarlós; Márta Varga; Béla Melegh
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

Review 4.  The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

Authors:  M Ellen Kuenzig; Jeff Yim; Stephanie Coward; Bertus Eksteen; Cynthia H Seow; Cheryl Barnabe; Herman W Barkema; Mark S Silverberg; Peter L Lakatos; Paul L Beck; Richard Fedorak; Levinus A Dieleman; Karen Madsen; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  EBioMedicine       Date:  2017-06-16       Impact factor: 8.143

Review 5.  The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.

Authors:  Dominika Jakubczyk; Katarzyna Leszczyńska; Sabina Górska
Journal:  Nutrients       Date:  2020-07-02       Impact factor: 5.717

Review 6.  A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances.

Authors:  Maheeba Abdulla; Nafeesa Mohammed
Journal:  Biologics       Date:  2022-09-12

7.  Association between CD14 gene C-260T polymorphism and inflammatory bowel disease: a meta-analysis.

Authors:  Zhengting Wang; Jiajia Hu; Rong Fan; Jie Zhou; Jie Zhong
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.